Concepedia

Publication | Open Access

Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues

418

Citations

61

References

2017

Year

TLDR

Despite increased use of human induced pluripotent stem cell‑derived cardiomyocytes for drug development and disease modeling, methods to generate large, functional heart tissues for therapy are lacking. The study aims to develop a Cardiopatch platform for 3D culture and maturation of hiPSC‑CMs. The platform supports 5‑week 3D differentiation that yields robust electromechanical coupling, consistent H‑zones, I‑bands, and evidence of T‑tubules and M‑bands. The Cardiopatch platform produces hiPSC‑CM tissues that mature toward adult myocardium, scale to clinically relevant sizes with uniform high conduction velocities and contractile stresses, vascularize and retain Ca²⁺ transients in vivo, engraft onto rat hearts without increasing arrhythmias, and thus enable future human heart repair.

Abstract

Despite increased use of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for drug development and disease modeling studies, methods to generate large, functional heart tissues for human therapy are lacking. Here we present a "Cardiopatch" platform for 3D culture and maturation of hiPSC-CMs that after 5 weeks of differentiation show robust electromechanical coupling, consistent H-zones, I-bands, and evidence for T-tubules and M-bands. Cardiopatch maturation markers and functional output increase during culture, approaching values of adult myocardium. Cardiopatches can be scaled up to clinically relevant dimensions, while preserving spatially uniform properties with high conduction velocities and contractile stresses. Within window chambers in nude mice, cardiopatches undergo vascularization by host vessels and continue to fire Ca2+ transients. When implanted onto rat hearts, cardiopatches robustly engraft, maintain pre-implantation electrical function, and do not increase the incidence of arrhythmias. These studies provide enabling technology for future use of hiPSC-CM tissues in human heart repair.

References

YearCitations

Page 1